PanaTimes

Tuesday, May 18, 2021
TV

Novavax Starts COVID-19 Vaccine Trials On Children Aged Between 12-17 Years

Novavax Starts COVID-19 Vaccine Trials On Children Aged Between 12-17 Years

Novavax said the trials would test "the efficacy (and) safety" of the vaccine, with participants receiving either the vaccine candidate or placebo in two doses, 21 days apart.
*Your email address will not be displayed on website
This article does not have any comments yet.
PanaTimes
×